atherosclerosis
Conditions
Interventions
control:placebo
group 1:fish oil (EPA+DHA620mg/d)
group 2:0.4mg/d folic acid+ 10.0 mg/dVB6
group3:0.4mg/d folic acid+ 10.0 mg/dVB6+fish oil (EPA+DHA620mg/d)
Sponsors
Qingdao University Medical College
Eligibility
Sex/Gender
All
Age
35 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1) Patients with the WHO diagnostic criteria for diagnosis of coronary heart disease (CHD) or by coronary angiography showed a major coronary arteries or multivessel coronary vascular stenosis greater than or equal to 50%; 2) Patients of screening in the first two months not taking omega-3 fatty acids, vitamins and minerals and other supplements; 3) Patients of voluntarily signed informed consent.
Exclusion criteria
Exclusion criteria: 1) Patients of severe liver and kidney disease, tumor, and peripheral vascular disease, recently had surgery and trauma patients; 2) Patients of complicated with other diseases, and researchers believe that affect curative effect evaluation or compliance claim; 3) Patients of any other reason, the researchers think not appropriate participants.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| blood lipids;Inflammatory factors;The cell signaling pathways of protein expression; | — |
Countries
China
Contacts
Public ContactLiang Hui
Outcome results
None listed